39

Innovative Pharmaceutical Biotech LtdHKG 399 Stock Report

Last reporting period 30 Sep, 2023

Updated 17 Sep, 2024

Last price

Market cap $B

0.019

Micro

Exchange

XHKG - Hong Kong Exchange

399.HK Stock Analysis

39

Uncovered

Innovative Pharmaceutical Biotech Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-10/100

Low score

Market cap $B

0.019

Dividend yield

Shares outstanding

1 464.19 B

Innovative Pharmaceutical Biotech Ltd. is an investment holding company, which engages in trading of beauty equipment and products. The company employs 23 full-time employees The company went IPO on 2008-07-18. The firm operates through five segments. Genetic Testing Services segment is engaged in the provision of genetic testing services in the People’s Republic of China (PRC) and Hong Kong. Bio-Industrial Products segment is engaged in the distribution of bio-industrial products in the PRC. Beauty Equipment and Products segment is engaged in the trading of beauty equipment and products in Hong Kong. Securities Investment segment is engaged in securities investment in Hong Kong and outside Hong Kong. Research and Development segment is engaged in the research, development and commercialization of the oral insulin products.

View Section: Eyestock Rating